Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy

American Journal of Neuroradiology

Volumn 21, Issue 3, 2000, Pages 479-484

  Bargalló, Nuria ^a   Burrel, Marta ^b   Berenguer, Joan ^b   Cofan, Federico ^b   Buñesch, Laura ^b   Mercader, Josep M ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; TACROLIMUS; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BRAIN NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC KIDNEY FAILURE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CEREBRAL CORTEX; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; NECROSIS; TACROLIMUS; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 0034112922     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jansen O, Krieger D, Krieger S, Sartor K. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol 1996; 17:337-344
2. Truwit CL, Denaro CP, Lake JR, et al. MRI imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659
3. Widjdicks EFM, Wiesnwe RH, Dahlke LJ, et al. FK 506-induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498-501
4. Byrd RL, Rohrbaugh TM, Raney RB, et al. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer 1981;47:37-40
5. Tuxen MK, Hansent SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 1994;20:191-214
6. Eidelman BH, Abu-Elmagd K, Wilson JJ, et al. Neurologic complications of FK 506. Transplant Proc 1991;23:3175-3178
7. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683-688
8. Tomura N, Kurosawa R, Kato K, et al. Transient neurotoxicity associated with FK 506: MRI findings. J Comput Assist Tomogr 1998;22:505-507
9. Burkhalter EL, Starzl TE, Van Thiel DH. Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol 1994;21: 572-577
10. Reyes J, Gayowski T, Fung J, et al. Expressive dysphasia possibly related to FK 506 in two liver transplant recipients. Transplantation 1990;50:1043-1081
11. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRI findings in 16 cases. AJR Am J Roentgenol 1995; 165:627-631
12. Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37: 1487-1491
13. Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporine A neurotoxicity. J Comput Assist Tomogr 1997;21:872-880
14. Heran F, Defer G, Brugieres P, et al. Cortical blindness during chemotherapy: clinical, CT and MR correlations. J Comput Assist Tomogr 1990;14:262-266
15. Jaffe N, Takaue Y, Anzai T, et al. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 1985;56:1356-1360
16. Fritsch G, Urban C. Transient encephalopathy during the late course of treatment with high-dose methotrexate. Cancer 1984; 53:1849-1851